214 related articles for article (PubMed ID: 9354338)
1. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease.
Oh S; Ri Y; Bennett MV; Trexler EB; Verselis VK; Bargiello TA
Neuron; 1997 Oct; 19(4):927-38. PubMed ID: 9354338
[TBL] [Abstract][Full Text] [Related]
2. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.
Abrams CK; Freidin MM; Verselis VK; Bennett MV; Bargiello TA
Brain Res; 2001 May; 900(1):9-25. PubMed ID: 11325342
[TBL] [Abstract][Full Text] [Related]
3. Altered assembly of gap junction channels caused by COOH-terminal connexin32 mutants of CMTX.
Barrio LC; Castro C; Gómez-Hernandez JM
Ann N Y Acad Sci; 1999 Sep; 883():526-9. PubMed ID: 10586291
[No Abstract] [Full Text] [Related]
4. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease.
Abrams CK; Oh S; Ri Y; Bargiello TA
Brain Res Brain Res Rev; 2000 Apr; 32(1):203-14. PubMed ID: 10751671
[TBL] [Abstract][Full Text] [Related]
5. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
Abrams CK; Bennett MV; Verselis VK; Bargiello TA
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
[TBL] [Abstract][Full Text] [Related]
6. Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.
Ressot C; Gomès D; Dautigny A; Pham-Dinh D; Bruzzone R
J Neurosci; 1998 Jun; 18(11):4063-75. PubMed ID: 9592087
[TBL] [Abstract][Full Text] [Related]
7. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
Ressot C; Bruzzone R
Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
[TBL] [Abstract][Full Text] [Related]
8. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease.
Bruzzone R; White TW; Scherer SS; Fischbeck KH; Paul DL
Neuron; 1994 Nov; 13(5):1253-60. PubMed ID: 7946361
[TBL] [Abstract][Full Text] [Related]
9. X-linked Charcot-Marie-Tooth disease and connexin32.
Fischbeck KH; Abel A; Lin GS; Scherer SS
Ann N Y Acad Sci; 1999 Sep; 883():36-41. PubMed ID: 10586227
[TBL] [Abstract][Full Text] [Related]
10. Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene.
Wang HL; Wu T; Chang WT; Li AH; Chen MS; Wu CY; Fang W
Brain Res Mol Brain Res; 2000 May; 78(1-2):146-53. PubMed ID: 10891594
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gap junction assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease.
Martin PE; Mambetisaeva ET; Archer DA; George CH; Evans WH
J Neurochem; 2000 Feb; 74(2):711-20. PubMed ID: 10646523
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
[TBL] [Abstract][Full Text] [Related]
13. Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations.
Nicholson GA; Yeung L; Corbett A
Neurology; 1998 Nov; 51(5):1412-6. PubMed ID: 9818870
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
[TBL] [Abstract][Full Text] [Related]
15. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study.
Birouk N; LeGuern E; Maisonobe T; Rouger H; Gouider R; Tardieu S; Gugenheim M; Routon MC; Léger JM; Agid Y; Brice A; Bouche P
Neurology; 1998 Apr; 50(4):1074-82. PubMed ID: 9566397
[TBL] [Abstract][Full Text] [Related]
16. Connexins in disease.
Bennett MV
Nature; 1994 Mar; 368(6466):18-9. PubMed ID: 8107878
[No Abstract] [Full Text] [Related]
17. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
18. Selective defects in channel permeability associated with Cx32 mutations causing X-linked Charcot-Marie-Tooth disease.
Bicego M; Morassutto S; Hernandez VH; Morgutti M; Mammano F; D'Andrea P; Bruzzone R
Neurobiol Dis; 2006 Mar; 21(3):607-17. PubMed ID: 16442804
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease.
Dubourg O; Tardieu S; Birouk N; Gouider R; Léger JM; Maisonobe T; Brice A; Bouche P; LeGuern E
Brain; 2001 Oct; 124(Pt 10):1958-67. PubMed ID: 11571214
[TBL] [Abstract][Full Text] [Related]
20. Cx32 hemichannel opening by cytosolic Ca2+ is inhibited by the R220X mutation that causes Charcot-Marie-Tooth disease.
Carrer A; Leparulo A; Crispino G; Ciubotaru CD; Marin O; Zonta F; Bortolozzi M
Hum Mol Genet; 2018 Jan; 27(1):80-94. PubMed ID: 29077882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
